Is Everolimus used in the treatment of Cowden's syndrome?
User rating for this question
Yes, what do you know about Cowden's syndrome? There is a lot of noise about Everolimus, via Novartis and it's use as a drug for cancer treatment. Since the primary function is Mtor inhibiting it would seem a good solution for CS treatment. Thoughts?
Posted Wed, 18 Dec 2013 in General Health
Answered by Dr. Sudarshan 1 hour later
Brief Answer: Possibility of use in cowdens syndrome Detailed Answer: Hi, Thanks for writing in. Cowden disease, also termed Cowden syndrome and multiple hamartoma syndrome, is an autosomal dominant condition with variable expression that results most commonly (80%) from a mutation in the PTEN gene. This condition cause hamartomatous neoplasms of the skin and mucosa, GI tract, bones, CNS, eyes, and genitourinary tract. As Everolimus has worked in cases of tuberous sclerosis which is a hamartomatous condition there is also possibility that it will work in Cowden's syndrome also. Although the genetic mutation are different (PTEN in cowden and TSC in tuberous sclerosis) there is a good possibility that everolimus can work in this condition also. However there have been no proper trials regarding everolimus in cowdens syndrome and it is an area of potential research. Hope this answers your query. Let me know if you need clarifications. Regards DrSudarshan. MD Dermatology
People also viewed
- Can detox cause labrinthyris
- Pins and needles in left side of chest in armpit
- Can depo cause low grade fever
- Does smokeless tobacco cause narrowing arteries
- Health problems tortuous carotid arteries
- Is tambocor used in the treatment of wpw syndrome ?
- Ekg normal test have artery blockage
- Treatment and cure for Cowden syndrome
- Is everolimus used in the treatment of cowdens syndrome
- Can stress cause a fetal demise
- Vertebral artery dissection shortness of breath
- Is periactin used in the treatment of cushing's syndrome?
- Does iron supplements cause period delay
- Can depo cause high pulse rate
- Is indocin used in the treatment of bartter syndrome?